Continue reading this on our app for a better experience

Open in App
Floating Button
Home News Company in the news

SGX rejects Thomson Medical application for further extension to restore public float

Bryan Wu
Bryan Wu • 1 min read
SGX rejects Thomson Medical application for further extension to restore public float
The company announced that it had received a letter of rejection from SGX-ST on Jan 10 after its application on Jan 2. Photo: Samuel Isaac Chua/The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Singapore Exchange Securities Trading (SGX-ST) has rejected Thomson Medical Group A50’s A50 application for a further extension of time to restore its public float.

The company announced that it had received a letter of rejection from SGX-ST on Jan 10 after its application on Jan 2.

SGX-ST had previously granted Thomson Medical an extension of one month until Jan 10 to explore options to restore its public float after the percentage of its shares held by public shareholders fell to 9.98% on Sept 12 last year.

This percentage of shares held by the public fell below SGX-ST’s requisite of 10% of the total number of issued shares excluding treasury shares. Companies that fall short of this requirement may be removed from the official SGX list.

Thomson Medical’s shares will continue trading while it continues to explore possible options to restore the float “as soon as possible”.

Shares in Thomson Medical closed 0.1 cents lower or 1.7% down at 5.8 cents on Jan 10.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.